1. Home
  2. ZH vs ORIC Comparison

ZH vs ORIC Comparison

Compare ZH & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZH
  • ORIC
  • Stock Information
  • Founded
  • ZH 2011
  • ORIC 2014
  • Country
  • ZH China
  • ORIC United States
  • Employees
  • ZH N/A
  • ORIC N/A
  • Industry
  • ZH Business Services
  • ORIC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZH Consumer Discretionary
  • ORIC Health Care
  • Exchange
  • ZH Nasdaq
  • ORIC Nasdaq
  • Market Cap
  • ZH 352.6M
  • ORIC 362.9M
  • IPO Year
  • ZH 2021
  • ORIC 2020
  • Fundamental
  • Price
  • ZH $3.88
  • ORIC $10.42
  • Analyst Decision
  • ZH Strong Buy
  • ORIC Strong Buy
  • Analyst Count
  • ZH 1
  • ORIC 8
  • Target Price
  • ZH $4.70
  • ORIC $18.83
  • AVG Volume (30 Days)
  • ZH 312.5K
  • ORIC 2.0M
  • Earning Date
  • ZH 08-21-2025
  • ORIC 08-11-2025
  • Dividend Yield
  • ZH N/A
  • ORIC N/A
  • EPS Growth
  • ZH N/A
  • ORIC N/A
  • EPS
  • ZH N/A
  • ORIC N/A
  • Revenue
  • ZH $464,095,225.00
  • ORIC N/A
  • Revenue This Year
  • ZH N/A
  • ORIC N/A
  • Revenue Next Year
  • ZH $7.46
  • ORIC N/A
  • P/E Ratio
  • ZH N/A
  • ORIC N/A
  • Revenue Growth
  • ZH N/A
  • ORIC N/A
  • 52 Week Low
  • ZH $2.55
  • ORIC $3.90
  • 52 Week High
  • ZH $6.32
  • ORIC $14.67
  • Technical
  • Relative Strength Index (RSI)
  • ZH 49.38
  • ORIC 71.78
  • Support Level
  • ZH $3.50
  • ORIC $8.85
  • Resistance Level
  • ZH $3.94
  • ORIC $10.99
  • Average True Range (ATR)
  • ZH 0.16
  • ORIC 0.69
  • MACD
  • ZH -0.00
  • ORIC 0.01
  • Stochastic Oscillator
  • ZH 53.03
  • ORIC 77.10

About ZH Zhihu Inc. (every two of each representing one ordinary share)

Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: